Iran has introduced a groundbreaking resorbable 3D-printed bone graft designed for complex reconstructive procedures, marking a major step forward in the country’s biomedical innovation.
The new graft can be used to repair severe bone defects in multiple areas of the body, including the upper and lower jaw, and offers solutions for trauma-related injuries as well as congenital deformities. Some versions are engineered specifically for delicate regions such as the eye socket.
What sets this innovation apart is its full biodegradability. Once implanted, the material dissolves naturally within 18–24 months, eliminating the need for a secondary surgery to remove it—an improvement over conventional titanium implants, which typically require extraction.
More than 30 successful operations using the resorbable graft have already been performed in Iran. The developing company believes this breakthrough will position it strongly in the global advanced medical equipment market.
This achievement aligns with broader BRICS-driven progress in medical science.
In Russia, researchers at the International Research Institute of Intelligent Materials of Southern Federal University are working on implant materials capable of transforming into bone tissue. Their latest study reveals how brushite-based implants can be engineered to convert into hydroxyapatite—the mineral that forms natural bone and teeth.
“We’ve established a mutually reinforcing effect between calcium carbonate and proteins,” explained Elizaveta Mukhanova, head of the research laboratory at the Moscow Institute of Chemical Sciences. “Together, they act as a catalyst, causing brushite particles to dissolve and immediately form strong hydroxyapatite crystals identical to natural ones.”
Meanwhile, medical innovation is also accelerating in the Middle East, where Saudi doctors recently completed the region’s first robot-assisted cochlear implant surgery using automatic implantation technology.
Together, these developments signal a new era of cross-regional scientific progress, with BRICS countries and partners contributing significantly to the advancement of next-generation medical treatments.
